Cargando…
Inhibition of TNF-α and JNK Signaling Pathway Can Reduce Paclitaxel-Induced Apoptosis of Mouse Cardiomyocytes
Paclitaxel (PTX) is a widely used chemotherapeutic drug for treating tumors. However, studies have shown that it can cause cardiac problems such as arrhythmia, myocarditis, chronic cardiomyopathy, and heart failure. Therefore, it is essential to study the mechanism behind the cardiotoxicity of PTX i...
Autores principales: | Ren, Shuang, Huang, Tianwen, Ou, Danyan, Feng, Luhuai, Huang, Sisi, Zhou, Chaonan, Ge, Lianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398847/ https://www.ncbi.nlm.nih.gov/pubmed/36016921 http://dx.doi.org/10.1155/2022/8460121 |
Ejemplares similares
-
Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
por: Yu‐Wei, Di, et al.
Publicado: (2020) -
TNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs
por: Chen, Zhang-Wei, et al.
Publicado: (2014) -
Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK/JNK signaling
por: Ou, Dongbo, et al.
Publicado: (2016) -
Role of JNK activation in paclitaxel-induced apoptosis in human head and neck squamous cell carcinoma
por: Lan, Yu-Yan, et al.
Publicado: (2021) -
NPR3 protects cardiomyocytes from apoptosis through inhibition of cytosolic BRCA1 and TNF-α
por: Lin, Dong, et al.
Publicado: (2016)